Washington, April 12 -- Humane World for Animals and Humane World Action Fund (formerly called the Humane Society of the United States and Humane Society Legislative Fund) welcomed the announcement by the U.S. Food and Drug Administration to phase out animal testing for certain monoclonal antibody therapies and drugs. This historic step includes a 3- to 5-year plan to make animal studies the exception rather than the norm for pre-clinical safety and toxicity testing. The FDA is prioritizing human-relevant science while seeking to reduce animal suffering. WASHINGTON-Humane World for Animals and Humane World Action Fund (formerly called the Humane Society of the United States and Humane Society Legislative Fund) welcomed the announcement by...